Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
290 Leser
Artikel bewerten:
(1)

Transparency Market Research: Single-use Bioprocessing Systems Market to Reach Value of US$ 8.95 Bn by 2028, TMR Study

  • Rising acceptance of single-use technologies in various manufacturing processes drives market growth
  • Increase in demand for biologics propels expansion of the global single-use bioprocessing systems industry

WILMINGTON, Del., Dec. 7, 2022 /PRNewswire/ -- The global single-use bioprocessing systems industry is estimated to rise at a CAGR of 11.5% during 2020 to 2028. Single-use or disposable bioprocessing equipment is used only once and subsequently disposed safely. They are made using sterilized plastic materials that are sealed off using gamma radiation before usage. These novel single-use systems are proving to be advantageous for end-users, as they feature quick product turnaround and are becoming increasingly affordable.

TMR_Logo_Logo

The last few years have seen significant increase in adoption of single-use solutions in both - pre-clinical, as well as clinical phases. Rise in adoption of single-use bioprocessing systems market technology-based production and manufacturing lines has resulted in these technologies becoming core and dominant in the pre-commercial segment of bio-pharmaceutical manufacturing. Additionally, advent of industrial automation processes and technologies, as well as intelligent bio-material manufacturing is also anticipated to foster market expansion during the next few years.

Get Exclusive PDF Sample Copy of Single-use Bioprocessing Systems Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3753

Single-use Bioprocessing Systems Market - Key Findings of the Report

  • Increase in Speed and Flexibility of Products to Augment Market Demand: Increasing demand for biologics, as well as growing instances of patent expiry of blockbuster drug formulations and molecules is anticipated to bolster market growth over the next decade. Furthermore, the speed and flexibility of these disposable and single-use systems is increasing with consistent technological advancements. Such market trends are also expected to have a positive effect on product demand in the coming years. Growing acceptance of single-use systems can be attributed to various benefits they offer, which include reduction of cost per usage, decreased need for water and energy for their production and operations, and saving time. Other notable advantages of using these solutions are reduced risk of cross contamination, their hassle-free nature, easy disposal, and increased productivity.

  • Rise in Acceptance of Single-use Technologies in Manufacturing Processes: Various advantages offered by single-use technologies in manufacturing has garnered attention from leading stakeholders in the bio-pharmaceutical sector. Single-use technologies have a unique feature, which enables customers to make certain changes according to their specific needs and then order their own customized version of single-use bioprocessing systems. Further, increasing production, owing to rise in demand for monoclonal antibodies, as well as vaccines, is also anticipated to bolster market expansion during the next decade. Other key applications include patient specific cell therapies, as well as cultivation of plant cells.

Single-use Bioprocessing Systems Market - Growth Drivers

  • Rising preference for single-use bioprocessing solutions and systems from bio-pharmaceutical companies propels market growth
  • Increase in geriatric population across the world that is more susceptible to chronic illnesses, drives market expansion
  • Growing prevalence of chronic kidney diseases, cardiovascular diseases, cancer, hypertension, and diabetes drives market demand

Ask for References -https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=3753

Single-use Bioprocessing Systems Market - Key Players

Leading players assessed in the single-use bioprocessing systems market report are Eppendorf AG, Parker Hannifin Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Danaher Corporation, Meissner Filtration Products, Inc., PBS Biotech, Inc., GE Healthcare (General Electric Company), and Saint-Gobain. Players are focused on understanding and fulfilling specific demands of customers and offering customizable single-use containers, bags, and bioreactors. They are also undertaking extensive research and development initiatives in a bid to conduct speedier pilot studies and decrease their capital costs. Technological advancements remain one of the leading growth drivers for industry players. Stakeholders are focusing on adopting emerging technologies, such as automation, and intelligent bio-manufacturing.

Single-use Bioprocessing Systems Market: Segmentation

Single-use Bioprocessing Systems Market, by Product

  • Bioreactors and Fermenters
  • Mixers
  • Bags
  • Tubing
  • Filtration Devices
  • Bioprocess Containers
  • Sampling Systems
  • Connectors & Clamps
  • Probes & Sensors

Single-use Bioprocessing Systems Market, by Application

  • Monoclonal Antibody Production
  • Vaccine Production
  • Plant Cell Cultivation
  • Patient Specific Cell Therapies
  • Others

Single-use Bioprocessing Systems Market, by End-user

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CROs & CMOs
  • Academic and Research Institutes

Single-use Bioprocessing Systems Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=3753

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

DNA and Gene Cloning Services Market: The global DNA and gene cloning services market is anticipated to reach more than US$ 9.5 Bn by the end of 2031 at a CAGR of 13.7% from 2022 to 2031.

Mice Model Generation Market: The global mice model generation market is anticipated to reach more than US$ 918.4 Mn by 2031 at a CAGR of 8.1% from 2022 to 2031.

Cancer Biomarkers Market: The global cancer biomarkers market is anticipated to reach more than US$ 31.4 Bn by 2031 at a CAGR of 9.9% from 2022 to 2031.

Analytical Standards Market: The global analytical standards market is anticipated to reach more than US$ 2.29 Bn by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.

Mice Model Technologies Market: The global mice model technologies market is anticipated to reach US$ 3.2 Bn by 2031 at a CAGR of 7.4% from 2022 to 2031.

Soft Tissue Allografts Market: The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031 at a CAGR of 5.5% from 2022 to 2031.

Animal Genetics Market: The global animal genetics market is anticipated to reach more than US$ 9.1 Bn by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.

Transplant Drug Monitoring Assay Market: The global transplant drug monitoring assay market is anticipated to reach more than US$ 542 Mn by the end of 2031 at a CAGR of 11.0% from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/single-use-bioprocessing-systems-market-to-reach-value-of-us-8-95-bn-by-2028--tmr-study-301696923.html

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.